202 related articles for article (PubMed ID: 2000943)
1. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.
Reindel JF; Roth RA
Am J Pathol; 1991 Mar; 138(3):707-19. PubMed ID: 2000943
[TBL] [Abstract][Full Text] [Related]
2. Comparison of response of bovine and porcine pulmonary arterial endothelial cells to monocrotaline pyrrole.
Reindel JF; Hoorn CM; Wagner JG; Roth RA
Am J Physiol; 1991 Dec; 261(6 Pt 1):L406-14. PubMed ID: 1767861
[TBL] [Abstract][Full Text] [Related]
3. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
[TBL] [Abstract][Full Text] [Related]
4. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
Hoorn CM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1993 Jun; 120(2):281-7. PubMed ID: 8511798
[TBL] [Abstract][Full Text] [Related]
5. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo.
Lappin PB; Ross KL; King LE; Fraker PJ; Roth RA
Toxicol Appl Pharmacol; 1998 May; 150(1):37-48. PubMed ID: 9630451
[TBL] [Abstract][Full Text] [Related]
6. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells.
Taylor DW; Wilson DW; Lamé MW; Dunston SD; Jones AD; Segall HJ
Toxicol Appl Pharmacol; 1997 Mar; 143(1):196-204. PubMed ID: 9073608
[TBL] [Abstract][Full Text] [Related]
7. Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cells.
Hoorn CM; Roth RA
Br J Pharmacol; 1993 Oct; 110(2):597-602. PubMed ID: 8242234
[TBL] [Abstract][Full Text] [Related]
8. Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells.
Thomas HC; Lamé MW; Dunston SK; Segall HJ; Wilson DW
Toxicol Appl Pharmacol; 1998 Aug; 151(2):236-44. PubMed ID: 9707500
[TBL] [Abstract][Full Text] [Related]
9. Monocrotaline pyrrole interacts with actin and increases thrombin-mediated permeability in pulmonary artery endothelial cells.
Wilson DW; Lamé MW; Dunston SK; Taylor DW; Segall HJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):138-44. PubMed ID: 9772209
[TBL] [Abstract][Full Text] [Related]
10. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
Roth RA; Reindel JF
Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225
[TBL] [Abstract][Full Text] [Related]
11. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
Lappin PB; Roth RA
Toxicol Pathol; 1997; 25(4):372-80. PubMed ID: 9280120
[TBL] [Abstract][Full Text] [Related]
12. Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells.
Thomas HC; Lamé MW; Morin D; Wilson DW; Segall HJ
Am J Respir Cell Mol Biol; 1998 Jul; 19(1):129-42. PubMed ID: 9651189
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNA.
Thomas HC; Lamé MW; Wilson DW; Segall HJ
Toxicol Appl Pharmacol; 1996 Nov; 141(1):319-29. PubMed ID: 8917705
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monocrotaline pyrrole-induced DNA cross-linking in pulmonary artery endothelium.
Wagner JG; Petry TW; Roth RA
Am J Physiol; 1993 May; 264(5 Pt 1):L517-22. PubMed ID: 8498528
[TBL] [Abstract][Full Text] [Related]
15. Excess l-arginine restores endothelium-dependent relaxation impaired by monocrotaline pyrrole.
Cheng W; Oike M; Hirakawa M; Ohnaka K; Koyama T; Ito Y
Toxicol Appl Pharmacol; 2005 Sep; 207(3):187-94. PubMed ID: 16129112
[TBL] [Abstract][Full Text] [Related]
16. Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging.
Lee J; Reich R; Xu F; Sehgal PB
Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L715-28. PubMed ID: 19648287
[TBL] [Abstract][Full Text] [Related]
17. Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanism.
Shah M; Patel K; Sehgal PB
Am J Physiol Cell Physiol; 2005 Apr; 288(4):C850-62. PubMed ID: 15561761
[TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
Schultze AE; Gunaga KP; Wagner JG; Hoorn CM; Moorehead WR; Roth RA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):301-10. PubMed ID: 8209383
[TBL] [Abstract][Full Text] [Related]
19. 6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats.
Ganey PE; Roth RA
Exp Lung Res; 1987; 12(3):195-206. PubMed ID: 3107969
[TBL] [Abstract][Full Text] [Related]
20. 6-Ketoprostaglandin F1 alpha and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline pyrrole-treated rats.
Ganey PE; Roth RA
J Toxicol Environ Health; 1988; 23(1):127-37. PubMed ID: 3336057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
